# Autophagy is dysregulated in spinocerebellar ataxia type 2

**Authors:** Adriana Marcelo, Carlos A. Matos, Clévio Nóbrega

PMC · DOI: 10.1080/27694127.2022.2065603 · Autophagy Reports · 2022-04-20

## TL;DR

This paper explores how faulty autophagy contributes to neurodegeneration in spinocerebellar ataxia type 2.

## Contribution

It highlights autophagy dysregulation as a key factor in spinocerebellar ataxia type 2 pathology.

## Key findings

- Neuronal dysfunction and degeneration are linked to impaired autophagy.
- Protein clearance systems are critical for maintaining neuronal homeostasis.
- Autophagy inhibition alone can cause neurodegeneration in the central nervous system.

## Abstract

The accumulation of misfolded proteins and fibrillar aggregates inside neurons is a hallmark of several neurodegenerative diseases. While the exact role of these aggregates is still controversial, they are part of a cascade of molecular events that underlies the neuronal dysfunction and degeneration observed in these disorders. In this line, multiple studies on pathological events involved in neurodegenerative diseases have reported dysfunction of quality control mechanisms. In fact, the inhibition of macroautophagy/autophagy in the CNS per se, in the absence of additional stress stimuli, is sufficient to induce neurodegeneration. For neuronal homeostasis to be maintained, protein clearance systems must function properly, allowing the degradation of damaged organelles and pathogenic misfolded proteins. Therefore, in the last years there has been a strong focus on the study the dysregulation of protein clearance systems, especially autophagy, in the context of neurodegenerative diseases.

## Linked entities

- **Diseases:** spinocerebellar ataxia type 2 (MONDO:0008458)

## Full-text entities

- **Genes:** Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 66734] {aka 1010001H21Rik, 4922501H04Rik, LC3, LC3a}, Sqstm1 (sequestosome 1) [NCBI Gene 18412] {aka A170, OSF-6, Osi, STAP, STONE14, p62}, SQSTM1 (sequestosome 1) [NCBI Gene 8878] {aka A170, DMRV, EBIAP, FTDALS3, NADGP, OSIL}, ATXN2 (ataxin 2) [NCBI Gene 6311] {aka ATX2, SCA2, TNRC13}, Atxn2 (ataxin 2) [NCBI Gene 20239] {aka 9630045M23Rik, ATX2, Sca2}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}
- **Diseases:** neuroblastoma (MESH:D009447), neuropathological (MESH:D009422), polyQ diseases (MESH:D004194), neurodegeneration (MESH:D019636), spinocerebellar ataxia type 2 (MESH:D020754), neuroinflammation (MESH:D000090862), Polyglutamine (polyQ) diseases (MESH:D030342), MJD (MESH:D017827), polyQ disorder (MESH:D009358), neuronal death (MESH:D009410), inherited neurodegenerative conditions (MESH:D020271)
- **Chemicals:** cordycepin (MESH:C058120)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Neuro2a — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_0470)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11864612/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11864612/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11864612/full.md

---
Source: https://tomesphere.com/paper/PMC11864612